THE EFFECT OF PCSK9 INHIBITION IN FAMILIAL DYSBETALIPOPROTEINEMIA (TYPE III HYPERLIPOPROTEINEMIA): 4 CASES.
- Resource Type
- Article
- Source
Journal of the American College of Cardiology (JACC) . Mar2018 Supplement, Vol. 71, pA1759-A1759. 1p.- Subject
- Language
- ISSN
- 0735-1097